FilingSEC EDGAR8-K
Turn Therapeutics Releases Updated Investor Presentation on GX-03 Pipeline
· SEC accepted
StagePhase 2 Ongoing
Filing content
Turn Therapeutics released an updated investor presentation detailing the clinical development status and upcoming milestones for its GX-03 pipeline, including programs for atopic dermatitis, onychomycosis, and hidradenitis suppurativa.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…